Acute Megakaryoblastic Leukemia Cells (AMKLC)
Acute megakaryoblastic leukemia (AMKL) is a form of leukemia where a majority of the blasts are megakaryoblastic. It is classified under AML-M7 category of the French-American-British classification. It is associated with GATA1, and risks are increased in individuals with Down syndrome. A megakaryoblastic cell line, designated MEG-01, was established from the bone marrow of a patient with blast crisis of Philadelphia (Ph1) chromosome-positive chronic myelogenous leukemia. MEG-01 cell line may provide a useful model for the study of human megakaryopoiesis and of the biosynthetic mechanisms of proteins unique to megakaryocytic lineage.
Organism species: Pan-species (General)
PRODUCT TYPE | CATALOG NO. | PRODUCT NAME | APPLICATIONS |
---|---|---|---|
Proteins | N/A | Recombinant Acute Megakaryoblastic Leukemia Cells (AMKLC) | Antigenic Transformation Customized Service Offer |
Antibodies | N/A | Monoclonal Antibody to Acute Megakaryoblastic Leukemia Cells (AMKLC) | Monoclonal Antibody Customized Service Offer |
N/A | Polyclonal Antibody to Acute Megakaryoblastic Leukemia Cells (AMKLC) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | N/A | CLIA Kit for Acute Megakaryoblastic Leukemia Cells (AMKLC) | CLIA Kit Customized Service Offer |
N/A | ELISA Kit for Acute Megakaryoblastic Leukemia Cells (AMKLC) | ELISA Kit Customized Service Offer |